HOWL CIK: 1785530

Werewolf Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.9
FY22:
−40.6
FY23:
−32.6
FY24:
−56.2
FY25:
−60.3
Change from FY21 to FY25
millions USD
FY21:
−0.50
FY22:
−3.61
FY23:
−0.77
FY24:
−0.25
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
15.9
FY23:
58.4
FY24:
13.1
FY25:
6.03
millions USD
FY21:
66.1
FY22:
−28.3
FY23:
25.0
FY24:
−43.4
FY25:
−54.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.4
FY22:
−44.2
FY23:
−33.4
FY24:
−56.4
FY25:
−60.3

All amounts in millions USD Data source:SEC EDGAR